RYBP stabilizes p53 by modulating MDM2
Open Access
- 19 December 2008
- journal article
- Published by Springer Nature in EMBO Reports
- Vol. 10 (2), 166-172
- https://doi.org/10.1038/embor.2008.231
Abstract
The mouse double minute 2 (MDM2)–p53 interaction regulates the activity of p53 and is a potential target for human cancer therapy. Here, we report that RYBP (RING1‐ and YY1‐binding protein), a member of the polycomb group (PcG), interacts with MDM2 and decreases MDM2‐mediated p53 ubiquitination, leading to stabilization of p53 and an increase in p53 activity. RYBP induces cell‐cycle arrest and is involved in the p53 response to DNA damage. Expression of RYBP is decreased in human cancer tissues compared with adjacent normal tissues. These results show that RYBP is a new regulator of the MDM2–p53 loop and that it has tumour suppressor activity.This publication has 21 references indexed in Scilit:
- Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosisCancer Gene Therapy, 2008
- Mycophenolic Acid Activation of p53 Requires Ribosomal Proteins L5 and L11Journal of Biological Chemistry, 2008
- Proteasome activator PA28γ regulates p53 by enhancing its MDM2-mediated degradationThe EMBO Journal, 2008
- Ribosomal protein S27L is a direct p53 target that regulates apoptosisOncogene, 2006
- The Polycomb‐associated protein Rybp is a ubiquitin binding proteinFEBS Letters, 2006
- Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation InhibitionMolecular and Cellular Biology, 2004
- MDM2 Is a Negative Regulator of p21 , Independent of p53Journal of Biological Chemistry, 2004
- Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killingCell Death & Differentiation, 2004
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997